Genetics and epigenetics of systemic lupus erythematosus

Current Rheumatology Reports

Volumn 15, Issue 9, 2013, Pages

  Costa Reis, Patrícia ^a,b,c   Sullivan, Kathleen E ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Autoimmune diseases; Epigenetics; Genetics; Lupus; SLE; Systemic lupus erythematosus

Indexed keywords

AUTOIMMUNE DISEASE; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; REVIEW;

AUTOIMMUNE DISEASES; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 84881301739     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0369-4     Document Type: Article

References (100)

1. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35(3):311-8
2. Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: Recent progress from GWAS. J Autoimmun. 2013;41:25-33.
3. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40(9):1059-61.
4. HomG,GrahamRR,Modrek B, TaylorKE,OrtmannW, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13- BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900-9. (Pubitemid 351397089)
5. Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40(2):204-10. (Pubitemid 351171405)
6. Han J-W, Zheng H-F, Cui Y, Sun L-D, Ye D-Q, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41(11):1234-7.
7. Chung SA, Taylor KE, Graham RR, Nititham J, Lee AT, Ortmann WA, et al. Differential genetic associations for systemic lupus erythematosus based on Anti-dsDNA autoantibody production. de Bakker PIW, editor. Plos Genet. 2011;7(3):e1001323. Review of the recent contributions of GWAS to the understanding of SLE genetics.
8. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007;40 (8):560-6. (Pubitemid 350302182)
9. Sullivan KE. Complement deficiency and autoimmunity. Curr Opin Pediatr. 1998;10(6):600-6. (Pubitemid 28542785)
10. Lee YH,Witte T, Momot T, Schmidt RE, KaufmanKM, Harley JB, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: Two case-control studies and a metaanalysis. Arthritis Rheum. 2005;52(12):3966-74. (Pubitemid 41798236)
11. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 1996;39(12):2046-51. (Pubitemid 27009073)
12. øhlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannosebinding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med. 2004;351(3):260-7. (Pubitemid 38916043)
13. Manzi S, Urbach AH, McCune AB, Altman HA, Kaplan SS, Medsger Jr TA, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: Case report and review of the literature. Arthritis Rheum. 1991;34(1):101-5.
14. Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: Incidence and autoimmune serology. Clin Exp Immunol. 2007;148 (1):79-84. (Pubitemid 46364989)
15. Sanford AN, Suriano AR, Herche D, Dietzmann K, Sullivan KE. Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatol Oxf Engl. 2006;45(2):178-81. (Pubitemid 43160079)
16. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122(6):1097-103.
17. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268 (5215):1347-9.
18. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98(5):1107-13. (Pubitemid 26299922)
19. RamaswamyM, Siegel RM. Autoimmunity: Twenty years in the fas lane. J Immunol. 2012;189(11):5097-100.
20. Butbul Aviel Y, Mandel H, Avitan Hersh E, Bergman R, Adiv O, Luder A, et al. Prolidase deficiency associated with systemic lupus erythematosus (SLE): Single site experience and literature review. Pediatr Rheumatol. 2012;10(1):18.
21. Lee-KirschMA, Gong M, Chowdhury D, Senenko L, Engel K, Lee Y-A, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007;39(9):1065-7. (Pubitemid 47340647)
22. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 2011;12(4):270-9.
23. Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet. 2011;43(2):127-31.
24. Forton AC, Petri MA, Goldman D, Sullivan KE. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat. 2002;19(4):459.
25. Ramos PS, Oates JC, Kamen DL,Williams AH, Gaffney PM, Kelly JA, et al. Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry. J. Rheumatol. 2013.
26. Karassa FB, Trikalinos TA, Ioannidis JPA, FcgammaRIIa-SLE Meta-Analysis Investigators. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis. Arthritis Rheum. 2002;46 (6):1563-71. (Pubitemid 34620203)
27. Koene HR, Kleijer M, Swaak AJ, Sullivan KE, Bijl M, Petri MA, et al. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 1998;41(10):1813-8. (Pubitemid 28465535)
28. Oh M, Petri MA, Kim NA, Sullivan KE. Frequency of the Fc gamma RIIIA-158F allele in African American patients with systemic lupus erythematosus. J Rheumatol. 1999;26(7):1486-9. (Pubitemid 29317869)
29. Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 2002;46 (5):1242-54. (Pubitemid 34525832)
30. Kono H, Kyogoku C, Suzuki T, Tsuchiya N, Honda H, Yamamoto K, et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet. 2005;14(19):2881-92. (Pubitemid 41418793)
31. Magnusson V, Zunec R, Odeberg J, Sturfelt G, Truedsson L, Gunnarsson I, et al. Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum. 2004;50(4):1348-50. (Pubitemid 38480847)
32. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A, et al. Loss of function of a lupusassociated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med. 2005;11(10):1056-8. (Pubitemid 41486826)
33. Karassa FB, Trikalinos TA, Ioannidis JPA. Fc gamma RIIIA-SLE meta-analysis investigators. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis. Kidney Int. 2003;63(4):1475-82. (Pubitemid 36350013)
34. Alarcón GS, McGwin Jr G, Petri M, Ramsey-Goldman R, Fessler BJ, Vilá LM, et al. Time to renal disease and end-stage renal disease in PROFILE: A multiethnic lupus cohort. Plos Med. 2006;3(10): e396.
35. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expressionand immune complex uptake. J Exp Med. 2008;205(7):1573-82. (Pubitemid 351962021)
36. Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. Plos Genet. 2011;7(5):e1002079
37. Bronson PG, Chaivorapol C, Ortmann W, Behrens TW, Graham RR. The genetics of type I interferon in systemic lupus erythematosus. Curr Opin Immunol. 2012;24(5):530-7.
38. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003;100(5):2610-5. (Pubitemid 36297546)
39. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MGE, et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004;50 (12):3958-67. (Pubitemid 39643944)
40. Crow MK, Kirou KA. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol. 2004;16(5):541-7.
41. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, et al. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011;63(4):1044-53.
42. Ko K, Franek BS, MarionM, Kaufman KM, Langefeld CD, Harley JB, et al. Genetic ancestry, serum interferon-a activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol. 2012;39 (6):1238-40.
43. Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, et al. Sexspecific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2010;107(36):15838-43.
44. Cunninghame Graham DS,Morris DL, Bhangale TR, Criswell LA, Syvänen A-C, Rönnblom L, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. Plos Genet. 2011;7(10):e1002341.
45. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12 (3):231-8.
46. Nordang GBN, Viken MK, Amundsen SS, Sanchez ES, Flatø B, Førre OT, et al. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts. Rheumatol Oxf Engl. 2012;51(4):619-26.
47. Sigurdsson S,NordmarkG,Göring HHH, LindroosK,Wiman A-C, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet. 2005;76(3):528-37. (Pubitemid 40250533)
48. Graham RR, Kozyrev SV, Baechler EC, ReddyMVPL, Plenge RM, Bauer JW, et al.A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38 (5):550-5.
49. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LRL, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 2007;104(16):6758-63. (Pubitemid 47175574)
50. Shin HD, Sung Y-K, Choi C-B, Lee SO, Lee HW, Bae S-C. Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther. 2007;9(2):R32.
51. Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun. 2008;9(3):187-94. (Pubitemid 351584185)
52. Niewold TB, Kelly JA, FleschMH, Espinoza LR, Harley JB, Crow MK. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 2008;58(8):2481-7.
53. Cham CM, Ko K, Niewold TB. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:780436.
54. Feng D, Yang L, Bi X, Stone RC, Patel P, Barnes BJ. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur J Immunol. 2012;42 (6):1477-87.
55. Fu Q, Zhao J, Qian X, Wong JLH, Kaufman KM, Yu CY, et al. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum. 2011;63(3):749-54.
56. Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010;62(2):553-61.
57. Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, et al. Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population. Lupus. 2012;21(8):890-5.
58. Gateva V, Sandling JK, HomG, TaylorKE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41(11):1228-33.
59. Wang S, Adrianto I, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 2012;13(5):380-7.
60. Wang D, John SA, Clements JL, Percy DH, Barton KP, Garrett-Sinha LA. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol. 2005;17(9):1179-91. (Pubitemid 41236075)
61. Sullivan KE, Piliero LM, Dharia T, Goldman D, Petri MA. 3' polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum Mutat. 2000;16(1):49-53. (Pubitemid 30447968)
62. Yang W, Shen N, Ye D-Q, Liu Q, Zhang Y, Qian X-X, et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. Plos Genet. 2010;6(2):e1000841.
63. Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Koskinen LLE, Jeskanen L, et al. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. Exp Dermatol. 2010;19(2):123-31.
64. Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci. 2009;106(15):6256-61.
65. Zhai Y, Xu K, Leng R-X, Cen H,WangW, Zhu Y, et al. Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population. Inflamm Res. 2013;62(6):555-60.
66. Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet. 2011;43(3):253-8.
67. Sheng Y-J, Gao J-P, Li J, Han J-W, Xu Q, HuW-L, et al. Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatol Oxf Engl. 2011;50 (4):682-8.
68. Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40(9):1062-4.
69. Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, et al. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 2009;10(5):470-7.
70. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350-4.
71. Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, Rhee L, et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity. 2010;33(2):181-91
72. Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet. 2008;40(2):152-4. (Pubitemid 351171399)
73. Kim-Howard X, Maiti AK, Anaya J-M, Bruner GR, Brown E, Merrill JT, et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosuswith European ancestry. Ann Rheum Dis. 2010;69(7):1329-32.
74. Vaughn SE, Kottyan LC, Munroe ME, Harley JB. Genetic susceptibility to lupus: The biological basis of genetic risk found in B cell signaling pathways. J Leukoc Biol. 2012;92(3):577-91. Detailed review of the SLE genetic risk factors associated with B-cell functioning.
75. Kozyrev SV, Abelson A-K, Wojcik J, Zaghlool A, Linga Reddy MVP, Sanchez E, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet. 2008;40(2):211-6. (Pubitemid 351171404)
76. Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 2009;10(5):397-403.
77. Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Mol Immunol. 2013;53(1-2):99-110.
78. Wu H, Boackle SA, Hanvivadhanakul P, Ulgiati D, Grossman JM, Lee Y, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2007 ;104(10):3961-6. (Pubitemid 47181561)
79. Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun. 2009;10(5):457-69.
80. Song GG, Choi SJ, Ji JD, Lee YH. Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: A meta-analysis. Hum Immunol. 2013;74(3):364-70.
81. Wang B, Zhu J-M, Fan Y-G, Xu W-D, Cen H, Pan H-F, et al. Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis. Gene. 2013;519(2):209-16.
82. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76(4):561-71. (Pubitemid 40432164)
83. Lee YH, Song GG. Associations between TNFSF4 and TRAF1-C5 gene polymorphisms and systemic lupus erythematosus: A metaanalysis. Hum Immunol. 2012;73(10):1050-4.
84. Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 2009;60(4):1085-95.
85. Zheng J, Yin J, Huang R, Petersen F, Yu X. Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody. Hum. Immunol. 2013 Apr 27.
86. Takeuchi T, Suzuki K. CD247 variants and single-nucleotide polymorphisms observed in systemic lupus erythematosus patients. Rheumatol. Oxf. Engl. 2013 Mar 22.
87. Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, et al. A comprehensive analysis of shared loci between Systemic Lupus Erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. Dermitzakis ET, editor. Plos Genet. 2011;7(12):e1002406.
88. Sullivan KE, Suriano A, Dietzmann K, Lin J, Goldman D, Petri MA. The TNFalpha locus is altered inmonocytes frompatients with systemic lupus erythematosus. Clin Immunol Orlando Fla. 2007;123 (1):74-81. (Pubitemid 46401512)
89. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q. Impaired DNA methylation and its mechanisms in CD4+T cells of systemic lupus erythematosus. J Autoimmun. 2013;41:92-9. Very complete description of DNA methylation impairment and its biological consequences in SLE.
90. Patel DR, Richardson BC. Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther. 2013;15(1):201.
91. Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, et al. Genome-wideDNAmethylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients. J. Autoimmun. 2013 Apr 24.
92. Zhang Z, Song L, Maurer K, Petri MA, Sullivan KE. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun. 2010;11(2):124-33.
93. Shen N, Liang D, Tang Y, de Vries N, Tak P-P. MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol. 2012;8(12):701-9. Interesting summary of the data regarding microRNAs in SLE.
94. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60(4):1065-75.
95. Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, et al. MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus. McCarthy MI, editor. Plos Genet. 2013;9(2):e1003336.
96. Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, et al. Circulating microrna expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1324-34.
97. Ding S, Liang Y, Zhao M, Liang G, Long H, Zhao S, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012;64(9):2953-63.
98. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and MicroRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting dna methyltransferase 1. J Immunol. 2010;184(12):6773-81.
99. SuiW, Hou X, CheW, YangM, Dai Y. The applied basic research of systemic lupus erythematosus based on the biological omics. Genes Immun. 2013;14(3):133-46. Comprehensive review on the recent advances in SLE genomics, epigenomics, proteomics and metabolomics.
100. Rullo OJ, Tsao BP. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis. 2012;72(Supplement 2): ii56-61